Alliancebernstein L.P. Ionis Pharmaceuticals Inc Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 52,162 shares of IONS stock, worth $1.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,162

Previous 51,268 1.74%

Holding current value

$1.91 Million

Previous $2.44 Million 14.49%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.06 - $51.86 $35,813 - $46,362	894 Added 1.74%	52,162 $2.09 Million
Q2 2024 Aug 14, 2024	SELL	$36.45 - $47.7 $5.1 Million - $6.67 Million	-139,887 Reduced 73.18%	51,268 $2.44 Million
Q1 2024 May 14, 2024	SELL	$42.03 - $53.55 $2.78 Million - $3.54 Million	-66,165 Reduced 25.71%	191,155 $8.29 Million
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $2.05 Million - $2.44 Million	-47,198 Reduced 15.5%	257,320 $13 Million
Q3 2023 Nov 14, 2023	SELL	$38.5 - $47.13 $1.62 Million - $1.98 Million	-42,020 Reduced 12.13%	304,518 $13.8 Million
Q2 2023 Aug 15, 2023	BUY	$34.73 - $43.33 $10.3 Million - $12.9 Million	297,938 Added 613.04%	346,538 $14.2 Million
Q1 2023 May 15, 2023	SELL	$33.58 - $41.2 $332,576 - $408,044	-9,904 Reduced 16.93%	48,600 $1.74 Million
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $14,922 - $18,701	402 Added 0.69%	58,504 $2.21 Million
Q3 2022 Nov 15, 2022	SELL	$36.54 - $48.66 $100,777 - $134,204	-2,758 Reduced 4.53%	58,102 $2.57 Million
Q2 2022 Aug 15, 2022	SELL	$31.71 - $43.0 $34,215 - $46,397	-1,079 Reduced 1.74%	60,860 $2.25 Million
Q1 2022 May 13, 2022	SELL	$29.88 - $37.04 $1.23 Million - $1.53 Million	-41,275 Reduced 39.99%	61,939 $2.29 Million
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $890,280 - $1.22 Million	34,763 Added 50.79%	103,214 $3.14 Million
Q3 2021 Nov 10, 2021	SELL	$33.54 - $40.55 $45,346 - $54,823	-1,352 Reduced 1.94%	68,451 $2.3 Million
Q2 2021 Jul 30, 2021	SELL	$34.54 - $47.25 $258,946 - $354,233	-7,497 Reduced 9.7%	69,803 $2.78 Million
Q1 2021 May 06, 2021	BUY	$42.51 - $63.78 $349,899 - $524,973	8,231 Added 11.92%	77,300 $3.48 Million
Q4 2020 Feb 08, 2021	SELL	$45.3 - $60.27 $27,180 - $36,162	-600 Reduced 0.86%	69,069 $3.91 Million
Q3 2020 Nov 12, 2020	BUY	$47.45 - $62.95 $3,796 - $5,036	80 Added 0.11%	69,669 $3.31 Million
Q2 2020 Aug 13, 2020	BUY	$46.85 - $61.05 $29,562 - $38,522	631 Added 0.92%	69,589 $4.1 Million
Q1 2020 May 14, 2020	SELL	$41.6 - $63.4 $18,054 - $27,515	-434 Reduced 0.63%	68,958 $3.26 Million
Q4 2019 Feb 18, 2020	BUY	$53.85 - $65.27 $43,510 - $52,738	808 Added 1.18%	69,392 $4.19 Million
Q3 2019 Nov 14, 2019	SELL	$59.06 - $72.15 $1,004 - $1,226	-17 Reduced 0.02%	68,584 $4.11 Million
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $67,305 - $93,375	1,084 Added 1.61%	68,601 $4.41 Million
Q1 2019 May 14, 2019	SELL	$52.92 - $81.17 $216,495 - $332,066	-4,091 Reduced 5.71%	67,517 $5.48 Million
Q4 2018 Feb 13, 2019	SELL	$43.37 - $59.54 $27,973 - $38,403	-645 Reduced 0.89%	71,608 $3.87 Million
Q3 2018 Nov 08, 2018	SELL	$42.88 - $53.7 $65,906 - $82,536	-1,537 Reduced 2.08%	72,253 $3.73 Million
Q2 2018 Aug 13, 2018	SELL	$40.53 - $50.7 $2.34 Million - $2.93 Million	-57,697 Reduced 43.88%	73,790 $3.08 Million
Q1 2018 May 14, 2018	BUY	$44.08 - $55.05 $2.59 Million - $3.24 Million	58,850 Added 81.02%	131,487 $5.8 Million
Q4 2017 Feb 13, 2018	SELL	$50.3 - $64.39 $30,180 - $38,634	-600 Reduced 0.82%	72,637 $3.65 Million
Q3 2017 Nov 13, 2017	BUY	$45.56 - $59.57 $3.34 Million - $4.36 Million	73,237	73,237 $3.71 Million

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.19B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Ionis Pharmaceuticals Inc Transaction History